* IMMUNID *
2005 - Rhône-Alpes
Grenoble
www.immunid.com Contract, Research
Key words: Personalized diagnostics, Combinatorial Repertoire analysis, Immunology analysis, Immunodeficiency, Immuno-monitoring, T & B cell repertoire, Genomic DNA, Infectious diseases, Auto-immune diseases, Blood cancers, Lymphoma and Leukemia diagnosis, ImmunTracker, ImmunIg
Mission: to provide third parties with innovative diagnostic and prognostic tools and high value-added services to decrease clinical study costs by selecting better immuno-drug candidates and by measuring immuno-reconstitution and suppression kinetics
Clients: Research labs, Hospitals, Pharmaceutical industry
info@immunid.com
Age: 4 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.-CEO: Pasqual (Nicolas) [co-founder, born 1977, Ph.D. molecular biology, ex-CEA]
Sc.Dir.-CSO: Pasqual (Nicolas)
Oper.Dir.-COO: Weisbuch (Sébastien) [born 1977, Ph.D. nanobiology, ex-CEA]
Tech.Dir.-CTO: Mouret (Jean-François) [Pharm.D., ex-Applied Biosystems, Cogenics, Genome Express (co-founder)]
Fin.Dir.-CFO:
BusDev: Plantier (Nadia)
Financers (Hist.): privately owned (registered capital 2006 = 0.053 M€)
Note : website revamped in March 2009 | Turnover (M€) : 0.08 (2008), 0.03 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Trade
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME | | 2009 .05 | 1st round-financing : 2.4 M€, by Vizille Capital Innovation (Vizille Capital Innovation & Sudinnova), SOFIMAC Partners and CEA Investissement | RFINA | [4 years] |
| 2009 .05 | Launch of Platine, a joint immuno-monitoring platform, by 5 partners (Innate Pharma, Transgene, ImmunID, Inserm and Cancer Centre Léon-Bérard), based in Lyon | MKTG | [4 years] |
| 2008 .12 | Financing (no interest loan) : 1.6 M€, by OSEO, to support its clinical development program of validation NDL biomarker and ImmunTraCkeR diagnostic test | DEBT | [3 years] |
| 2008 .09 | Licensing-in of a genomic analytical process from CEA and INSERM | LICIN | [3 years] |
| 2008 .01 | Partnering research agreement with Sanofi Pasteur | R&D | [2 years] |
| 2007 .07 | Certification : ISO 9001-2000 | INFO | [2 years] |
| 2005 .03 | Company founded by Nicolas Pasqual and Sébastien Weisbuch, for immunomonitoring and diagnostic solutions | ORGF | [0 year] | Actualisation / Updating: 29-Jun-2009 |
|
